|
EP3307390A1
|
|
Stem cell compositions for cosmetic and dermatologic use
|
|
WO2016081554A1
|
|
Immunogenic compositions prepared from tumor cells derived from peripheral blood and originating from a solid tumor and their use
|
|
WO2016048872A1
|
|
Compositions, methods and kits used to determine potency of dendritic cells in cancer immunitherpay
|
|
AU2014248711A1
|
|
Individualized high purity colon carcinoma stem cells, methods and use of the same
|
|
US2016022789A1
|
|
Individualized high purity colon carcinoma stem cells, methods and use of the same
|
|
US2016030537A1
|
|
Individualized High Purity Glioblastoma Multiforme Stem Cells and Methods for Stimulating Immune Response
|
|
US2016058855A1
|
|
High purity ovarian cancer stem cells for active autologous immune therapy
|
|
AU2014249344A1
|
|
Method of induction and purification of a cell population responsible for vasculary mimicry and use of the same
|
|
AU2014249346A1
|
|
High purity ovarian cancer stem cells for active autologous immune therapy
|
|
US2016017293A1
|
|
Individualized high purity hepatocellular carcinoma stem cells, methods and use of the same
|
|
NZ704003A
|
|
Bioreactor cartridge and system
|
|
AU2013215116A1
|
|
Pluripotent germ layer origin antigen presenting cancer vaccine
|
